Literature DB >> 1653814

Aversive conditioning in the rat: effects of a benzodiazepine and of an opioid agonist and antagonist on conditioned hypoalgesia and fear.

R F Westbrook1, J D Greeley, C P Nabke, A L Swinbourne.   

Abstract

Hypoalgesia and fear co-occurred in rats trained on a heated floor and tested for their latencies to paw lick on that floor and to step down onto a nonheated floor. These responses were extinguished, suggesting a mediation by aversive conditioning processes. A benzodiazepine impaired the acquisition of aversive conditioning, but it did not attenuate the expression of conditioned hypoalgesia. The opioid agonist morphine also impaired acquisition across a range of drug doses and variations in hypoalgesic tolerance, whereas the opioid antagonist naloxone facilitated acquisition. The results are discussed in terms of the perceptual-defensive-recuperative (Fanselow, 1986) and working memory (Grau, 1987) models of the mechanisms for the co-occurrence of conditioned hypoalgesia and fear.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653814     DOI: 10.1037//0097-7403.17.3.219

Source DB:  PubMed          Journal:  J Exp Psychol Anim Behav Process        ISSN: 0097-7403


  10 in total

1.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

2.  Blockade of endogenous opioid neurotransmission enhances acquisition of conditioned fear in humans.

Authors:  Falk Eippert; Ulrike Bingel; Eszter Schoell; Juliana Yacubian; Christian Büchel
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

3.  The Central Reinforcing Properties of Ethanol Are Mediated by Endogenous Opioid Systems: Effects of Mu and Kappa Opioid Antagonists.

Authors:  Michael E Nizhnikov; Elena I Varlinskaya; Norman E Spear
Journal:  Rev Argent Cienc Comport       Date:  2009

Review 4.  Anesthesia and the neurobiology of fear and posttraumatic stress disorder.

Authors:  Keith M Vogt; Kane O Pryor
Journal:  Curr Opin Anaesthesiol       Date:  2022-08-19       Impact factor: 2.733

5.  Low and high doses of midazolam differentially affect hypoalgesia in rats conditioned to a heat stressor.

Authors:  J A Harris; I S McGregor; R F Westbrook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

7.  Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion.

Authors:  J Broadbent; H V Linder; C L Cunningham
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

8.  Effects of midazolam and naloxone in rats tested for sensitivity/reactivity to formalin pain in a familiar, novel or aversively conditioned environment.

Authors:  J A Harris; R F Westbrook
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

9.  Pre-training naltrexone increases conditioned fear learning independent of adolescent alcohol consumption history.

Authors:  Alisa Pajser; Hayley Fisher; Charles L Pickens
Journal:  Physiol Behav       Date:  2020-10-16

10.  The Opioid Receptor Antagonist Naloxone Enhances First-Order Fear Conditioning, Second-Order Fear Conditioning and Sensory Preconditioning in Rats.

Authors:  Robine M L Michalscheck; Dana M Leidl; R Frederick Westbrook; Nathan M Holmes
Journal:  Front Behav Neurosci       Date:  2021-12-06       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.